New Delhi: India’s apex drug regulator, which had last September suspended approval for the launch of eye drops projected as ...

Now, there could be another alternative, in the form of eye drops administered daily, according to AbbVie's Allergan subsidiary, which reported new phase 3 data for its pilocarpine formulation ...

UCD and Galway spin-out Lia Eyecare wants to become the standard of care for overnight dry eye disease treatment with its ...

Allergan has confirmed that it will divest experimental ... impairment charge caused by delays in clinical studies and a drop in the expected value of some R&D projects. Allergan said it had ...

Credit unions across the country saw member savings and loans, particularly mortgages, increase over the latest financial ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

As soon as you enter, you’ll be given a disposable camera which you can drop off back at the space to get the photos ... fun ...

The company also owns Irish-headquartered Allergan, which manufactures the ... outperforming a roughly 7% drop in the S&P 500 Index. Investors have been focused on how companies are navigating ...

Despite today’s drop, the company’s shares are up more than 50% so far ... Its core product Jeuveau, a rival to Allergan’s Botox, is manufactured in South Korea and imported into the U.S. Shares of ...

So Allergan's profile is not dissimilar from ours ... And then when we look over the course of the year, 60% to 70% of the patients will drop. Now there's a variety of factors that drive that ...

The company's EPS missed by $0.10 in the last quarter, leading to a 0.0% drop in the share price on ... The 2020 acquisition of Allergan added several new products and drugs in aesthetics ...